UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
x | Filed by the Registrant |
¨ | Filed by a Party other than the Registrant |
Check the appropriate box: | |
¨ | Preliminary Proxy Statement |
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
¨ | Definitive Proxy Statement |
x | Definitive Additional Materials |
¨ | Soliciting Material under §240.14a-12 |
OCUGEN, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply): | |
x | No fee required |
¨ | Fee paid previously with preliminary materials |
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
This filing relates to the 2022 Annual Meeting of Stockholders of Ocugen, Inc. (the “Company”).
The following communication was made available by the Company on Twitter on May 24, 2022:
Proxy season is here! Ballots are in the mail 📬 Casting your vote 🗳️ is easy and important. And then join us for this year’s #AnnualMeeting of #Stockholders. Your voice matters! $OCGN